BIO Innovations Europe 2026

Invest Lithuania at Bio Innovations Europe 2026: Scaling Industrial Biomanufacturing

Invest Lithuania is heading to The Hague for Bio Innovations Europe, the continent’s premier event dedicated to the commercialization and scaling of industrial biomanufacturing. As Europe accelerates its transition toward a circular bioeconomy, Lithuania stands out as a strategic gateway for ambitious companies looking to bridge the gap between lab-scale innovation and high-volume industrial production.

Why Lithuania is the Choice for Bio-Innovation

With a robust heritage in Life Sciences and a fast-growing, agile biotech ecosystem, Lithuania offers a unique value proposition for bio-developers and chemical manufacturers. We don’t just offer a location; we offer a partnership designed for scale.

• Infrastructure for Scale: Lithuania provides specialized R&D hubs and state-of-the-art manufacturing facilities. These are specifically designed to support the rigorous demands of scaling bio-based solutions from pilot projects to global market readiness.
• Green Energy & Sustainability: Aligning with the EU’s defossilization agenda, Lithuania’s heavy investment in renewable energy ensures that your biomanufacturing processes meet the highest environmental standards, helping you achieve true carbon neutrality.
• A Collaborative Ecosystem: Seamlessly integrating government support, world-class academia, and private enterprise creates a streamlined, low-barrier path for FDI and long-term sustainable growth.

Connecting at Bio Innovations Europe

The event’s emphasis on high-value, pre-arranged 1-2-1 meetings aligns perfectly with our proactive, results-oriented approach. We are eager to engage with bio-pioneers, global investors, and consumer brands to discuss how Lithuania’s exceptional talent pool and business-friendly environment can serve as the primary foundation for your European expansion.

Whether you are navigating the complexities of the new EU Biotech Act or seeking a strategic location with superior logistics and operational cost-efficiencies, our team is ready to provide tailored, data-driven insights. Let’s collaborate in The Hague to drive the commercialization of the bioeconomy and make bio-based products the new global normal.